Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion: 2011-2025

Historic Depreciation and Depletion for China Pharma Holdings (CPHI) over the last 10 years, with Sep 2025 value amounting to $158,076.

  • China Pharma Holdings' Depreciation and Depletion fell 67.95% to $158,076 in Q3 2025 from the same period last year, while for Sep 2025 it was $800,921, marking a year-over-year decrease of 66.63%. This contributed to the annual value of $2.2 million for FY2024, which is 14.19% down from last year.
  • Latest data reveals that China Pharma Holdings reported Depreciation and Depletion of $158,076 as of Q3 2025, which was down 3.32% from $163,503 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Depreciation and Depletion peaked at $966,956 during Q3 2021, and registered a low of $158,076 during Q3 2025.
  • Its 3-year average for Depreciation and Depletion is $463,400, with a median of $624,721 in 2023.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first skyrocketed by 45.54% in 2021, then plummeted by 74.32% in 2025.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Depreciation and Depletion stood at $701,100 in 2021, then fell by 10.03% to $630,781 in 2022, then increased by 0.44% to $633,577 in 2023, then plummeted by 51.43% to $307,741 in 2024, then slumped by 67.95% to $158,076 in 2025.
  • Its Depreciation and Depletion was $158,076 in Q3 2025, compared to $163,503 in Q2 2025 and $171,601 in Q1 2025.